Summary
10 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $133.3M against $5.34M.
- The share price is below the Bulios Fair Price.
What to watch
- Revenue fell by 16% a year over the last 3 years.
- It missed profit estimates 5 times in the last 8 quarters.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Is it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 37% a year over 5 years. Over the last 3 years it fell by 16% a year.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $138.2M.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $285 is 217% above today's price. 60% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- License, Non-Affiliate 100%
By region
The company reports no revenue by region.
License, Non-Affiliate brings in 100% of revenue.
Segments in detail